Subclinical cardiovascular disease in plaque psoriasis: Association or causal linkα

Atherosclerosis

Volumn 232, Issue 1, 2014, Pages 72-78

  Shaharyar, Sameer ^a   Warraich, Haider ^b   McEvoy, John W ^d   Oni, Ebenezer ^a   Ali, Shozab S ^a   Karim, Adil ^a   Jamal, Omar ^a   Blaha, Michael J ^d   Blumenthal, Roger S ^d   Fialkow, Jonathan ^e   Cury, Ricardo ^c,e   Budoff, Matthew J ^f   Agatston, Arthur A ^a   Nasir, Khurram ^a,c,d,e,g  

^a Baptist Health South Florida   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e BAPTIST HOSPITAL OF MIAMI   (United States)

^f HARBOR UCLA MEDICAL CENTER   (United States)

^g FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Carotid intima media thickness; Coronary artery calcium; Primary prevention; Psoriasis; Sub endothelial dysfunction

Indexed keywords

ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CARDIOVASCULAR PARAMETERS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATATION; HUMAN; PRIORITY JOURNAL; PSORIASIS VULGARIS; PULSE WAVE; REVIEW; SUBCLINICAL ATHEROSCLEROSIS; SYSTEMATIC REVIEW;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY CALCIUM; PRIMARY PREVENTION; PSORIASIS; SUB-ENDOTHELIAL DYSFUNCTION;

ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; COMORBIDITY; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; INFLAMMATION; PSORIASIS; RISK; VASCULAR STIFFNESS;

EID: 84891616099     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.023     Document Type: Review

References (37)

1. National Psoriasis Foundation About psoriasis: statistics 2012, [accessed December 2012]. http://www.psoriasis.org/about/stats.
2. Abuabara K., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B., Gelfand J.M. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 2010, 163(3):586-592.
3. Driessen R.J., Boezeman J.B., Van De Kerkhof P.C., De Jong E.M. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies. JDermatolog Treat 2009, 20(1):42-47.
4. Kaye J.A., Li L., Jick S.S. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008, 159(4):895-902.
5. Mehta N.N., Yu Y., Pinnelas R., et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 2011, 124(8):775. e1-6.
6. Yang Y.W., Keller J.J., Lin H.C. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol 2011, 165(5):1037-1043.
7. Mehta N.N., Krishnamoorthy P., Yu Y., et al. The impact of psoriasis on 10-year Framingham risk. JAm Acad Dermatol 2012, 67(4):796-798.
8. Mehta N.N., Azfar R.S., Shin D.B., Neimann A.L., Troxel A.B., Gelfand J.M. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J 2010, 31(8):1000-1006.
9. Gaeta M., Castelvecchio S., Ricci C., Pigatto P., Pellissero G., Cappato R. Role of psoriasis as independent predictor of cardiovascular disease: a meta-regression analysis. Int J Cardiol 2013, 168(3):2282-2288.
10. Puzenat E., Bronsard V., Prey S., et al. What are the best outcome measures for assessing plaque psoriasis severityα A systematic review of the literature. JEur Acad Dermatol Venereol 2010, 24(Suppl.2):10-16.
11. Ludwig R.J., Herzog C., Rostock A., et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007, 156(2):271-276.
12. Yiu K.H., Yeung C.K., Zhao C.T., et al. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis. JIntern Med 2013, 273(3):273-282.
13. Arias-Santiago S., Orgaz-Molina J., Castellote-Caballero L., et al. Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis. Eur J Dermatol 2012, 22(3):337-344.
14. Balci D.D., Balci A., Karazincir S., et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. JEur Acad Dermatol Venereol 2009, 23(1):1-6.
15. El-Mongy S., Fathy H., Abdelaziz A., et al. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. JEur Acad Dermatol Venereol 2010, 24(6):661-666.
16. Enany B., El Zohiery A.K., Elhilaly R., Badr T. Carotid intima-media thickness and serum leptin in psoriasis. Herz 2012, 37(5):527-533.
17. Troitzsch P., Paulista Markus M.R., Dorr M., et al. Psoriasis is associated with increased intima-media thickness - the study of health in Pomerania (SHIP). Atherosclerosis 2012, 225(2):486-490.
18. De Simone C., Di Giorgio A., Sisto T., et al. Endothelial dysfunction in psoriasis patients: cross-sectional case-control study. Eur J Dermatol 2011, 21(4):510-514.
19. Karadag A.S., Yavuz B., Ertugrul D.T., et al. Is psoriasis a pre-atherosclerotic diseaseα Increased insulin resistance and impaired endothelial function in patients with psoriasis. Int J Dermatol 2010, 49(6):642-646.
20. Martyn-Simmons C.L., Ranawaka R.R., Chowienczyk P., et al. Aprospective case-controlled cohort study of endothelial function in patients with moderate to severe psoriasis. Br J Dermatol 2011, 164(1):26-32.
21. Ulusoy R.E., Karabudak O., Yokusoglu M., Kilicaslan F., Kirilmaz A., Cebeci B.S. Noninvasive assessment of impaired endothelial function in psoriasis. Rheumatol Int 2010, 30(4):479-483.
22. Usta M., Yurdakul S., Aral H., et al. Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients. Clin Biochem 2011, 44(13):1080-1084.
23. Osto E., Piaserico S., Maddalozzo A., et al. Impaired coronary flow reserve in young patients affected by severe psoriasis. Atherosclerosis 2012, 221(1):113-117.
24. Gisondi P., Fantin F., Del Giglio M., et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009, 218(2):110-113.
25. Gelfand J.M., Neimann A.L., Shin D.B., Wang X., Margolis D.J., Troxel A.B. Risk of myocardial infarction in patients with psoriasis. JAm Med Assoc 2006, 296(14):1735-1741.
26. Armstrong A.W., Harskamp C.T., Ledo L., Rogers J.H., Armstrong E.J. Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol 2012, 109(7):976-980.
27. Ridker P.M., Fonseca F.A., Genest J., et al. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. Am J Cardiol 2007, 100(11):1659-1664.
28. Kronmal R.A., McClelland R.L., Detrano R., et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2007, 115(21):2722-2730.
29. Sarwar A., Shaw L.J., Shapiro M.D., et al. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging 2009, 2(6):675-688.
30. Blacher J., Asmar R., Djane S., London G.M., Safar M.E. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999, 33(5):1111-1117.
31. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99(18):2434-2439.
32. Kremers H.M., McEvoy M.T., Dann F.J., Gabriel S.E. Heart disease in psoriasis. JAm Acad Dermatol 2007, 57(2):347-354.
33. Boehncke W.H., Boehncke S., Tobin A.M., Kirby B. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011, 20(4):303-307.
34. de la Llera Moya M., McGillicuddy F.C., Hinkle C.C., et al. Inflammation modulates human HDL composition and function invivo. Atherosclerosis 2012, 222(2):390-394.
35. Mehta N.N., Li R., Krishnamoorthy P., et al. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis 2012, 224(1):218-221.
36. Friedewald V.E., Cather J.C., Gelfand J.M., et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008, 102(12):1631-1643.
37. Trembath R.C., Clough R.L., Rosbotham J.L., et al. Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997, 6:813-820.